Ouro Medicines, a biotechnology company developing immune reset therapeutics for people living with chronic, immune-mediated ...
Living with an autoimmune disease often means navigating a lifelong, complex condition. A recent study estimates that ...
MedPage Today on MSN
Double-Action Lupus Drug Looks Good in Phase III Trial
A novel drug for systemic lupus erythematosus (SLE) first developed in China, and approved there since 2021, did well enough in a new placebo-controlled phase III trial that approval in Western ...
Please provide your email address to receive an email when new articles are posted on . A “complete eradication” of B cells with chimeric antigen receptor T-cell therapy is responsible for the ...
Researchers have developed a nanoparticle vaccine that prevented melanoma, pancreatic and triple-negative breast cancer in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results